177 related articles for article (PubMed ID: 19080358)
1. Prognostic analysis of refractory anaemia in adult myelodysplastic syndromes.
Wang XQ; Chen ZX; Chen SC; Lin GW; Ji MR; Liang JY; Liu DD; Li DG; Ma Y
Chin Med J (Engl); 2008 Sep; 121(18):1787-91. PubMed ID: 19080358
[TBL] [Abstract][Full Text] [Related]
2. [Establishment of Primary Adult MDS Nested Case-Control Study Cohort and Study of Risk Factors Associated with MDS Evolution to Leukemia].
Ma Y; Chen BB; Wang XQ; Xu XP; Lin GW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1638-46. PubMed ID: 26708886
[TBL] [Abstract][Full Text] [Related]
3. [The application of a new prognostic score system for 435 cases of primary myelodysplastic syndrome diagnosed with WHO classification].
Wang XQ;
Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):633-7. PubMed ID: 19954053
[TBL] [Abstract][Full Text] [Related]
4. [Study on prognostic significances of different cytogenetic risk categories in patients with primary myelodysplastic syndromes].
Qu SQ; Liu XP; Xu ZF; Zhang Y; Qin TJ; Zhang TJ; Cui R; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):819-24. PubMed ID: 22339954
[TBL] [Abstract][Full Text] [Related]
5. Clinico-pathological analysis of myelodysplastic syndromes according to French-American-British classification and international prognostic scoring system.
Lau LG; Chng WJ; Liu TC; Tan LK; Ong KH; Mow BM; Kueh YK
Ann Acad Med Singap; 2004 Sep; 33(5):589-95. PubMed ID: 15531954
[TBL] [Abstract][Full Text] [Related]
6. Refractory cytopenia with unilineage dysplasia: analysis of prognostic factors and survival in 126 patients.
Breccia M; Latagliata R; Cannella L; Carmosino I; Santopietro M; Loglisci G; Federico V; Alimena G
Leuk Lymphoma; 2010 May; 51(5):783-8. PubMed ID: 20302387
[TBL] [Abstract][Full Text] [Related]
7. International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes.
Kao JM; McMillan A; Greenberg PL
Am J Hematol; 2008 Oct; 83(10):765-70. PubMed ID: 18645988
[TBL] [Abstract][Full Text] [Related]
8. [Scoring analysis on prognosis of 63 patients with melodysplastic syndrome].
Wei J; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):305-11. PubMed ID: 18426654
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
[TBL] [Abstract][Full Text] [Related]
10. Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies.
Huang TC; Ko BS; Tang JL; Hsu C; Chen CY; Tsay W; Huang SY; Yao M; Chen YC; Shen MC; Wang CH; Tien HF
Leukemia; 2008 Mar; 22(3):544-50. PubMed ID: 18094713
[TBL] [Abstract][Full Text] [Related]
11. Clinical prognostic factors for survival and risk of progression to acute myeloid leukemia in patients with myelodysplastic syndromes with < 10% marrow blasts and non-unfavorable cytogenetic categories.
Falantes JF; Calderón C; Márquez Malaver FJ; Alonso D; Martín Noya A; Carrillo E; Martino ML; Montero I; González J; Parody R; Espigado I; Pérez-Simón JA
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):144-52. PubMed ID: 23137720
[TBL] [Abstract][Full Text] [Related]
12. The myelodysplastic syndromes: analysis of prognostic factors and comparison of prognostic systems in 128 Chinese patients from a single institution.
Zhao WL; Xu L; Wu W; Yan H; Tang W; Hu J; Chen Y; Li JM; Zeng XY; Xiong SM; Shen ZX; Chen Z; Wang ZY; Chen SJ
Hematol J; 2002; 3(3):137-44. PubMed ID: 12111649
[TBL] [Abstract][Full Text] [Related]
13. Impacts of cytogenetic categories in the Revised International Prognostic Scoring System on the prognosis of primary myelodysplastic syndromes: results of a single-center study.
Qu S; Xu Z; Zhang Y; Qin T; Zhang T; Cui R; Xiao Z
Leuk Lymphoma; 2012 May; 53(5):940-6. PubMed ID: 22023524
[TBL] [Abstract][Full Text] [Related]
14. Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes.
Berer A; Jäger E; Sagaster V; Streubel B; Wimazal F; Sperr WR; Welterman A; Schwarzinger I; Frommlet F; Haas OA; Valent P; Lechner K; Geissler K; Ohler L
Ann Hematol; 2003 May; 82(5):271-7. PubMed ID: 12739063
[TBL] [Abstract][Full Text] [Related]
15. A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q- syndrome from refractory anemia in primary myelodysplastic syndrome.
Cermák J; Michalová K; Brezinová J; Zemanová Z
Leuk Res; 2003 Mar; 27(3):221-9. PubMed ID: 12537974
[TBL] [Abstract][Full Text] [Related]
16. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.
Schanz J; Tüchler H; Solé F; Mallo M; Luño E; Cervera J; Granada I; Hildebrandt B; Slovak ML; Ohyashiki K; Steidl C; Fonatsch C; Pfeilstöcker M; Nösslinger T; Valent P; Giagounidis A; Aul C; Lübbert M; Stauder R; Krieger O; Garcia-Manero G; Faderl S; Pierce S; Le Beau MM; Bennett JM; Greenberg P; Germing U; Haase D
J Clin Oncol; 2012 Mar; 30(8):820-9. PubMed ID: 22331955
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic features and prognosis analysis in Chinese patients with myelodysplastic syndrome: a multicenter study.
Wang H; Wang X; Xu X; Lin G
Ann Hematol; 2010 Jun; 89(6):535-44. PubMed ID: 19921190
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System.
van Spronsen MF; Ossenkoppele GJ; Westers TM; van de Loosdrecht AA
Eur J Cancer; 2016 Mar; 56():10-20. PubMed ID: 26798967
[TBL] [Abstract][Full Text] [Related]
19. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I
Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
[TBL] [Abstract][Full Text] [Related]
20. Serum ferritin is an independent prognostic factor in Chinese with myelodysplastic syndromes classified as IPSS Intermediate-1.
Li B; Xu Z; Gale RP; Qin T; Zhang Y; Xiao Z
Acta Haematol; 2013; 129(4):243-50. PubMed ID: 23328695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
